News

? Seasoned drug hunter Siegfried Reich has left eFFECTOR, the biotech he co-founded to discover selective translation regulators, to take up the CSO role at Turning Point Therapeutics.
“I have followed the progress Turning Point has made, and was drawn… […]

Five months after a huge Phase III failure triggered mass layoffs at the company, Tocagen will sign itself out of existence.
Paul Wagner
The biotech, once focused on brain cancer, announced it has signed a reverse merger agreement with Forte Bioscience… […]

Scientists at Sanford Burnham Prebys Medical Discovery Institute and Harvard University have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell’s nucleus—and identified an FDA-approv… […]

SAN DIEGO–(BUSINESS WIRE)– #bio–Calidi Biotherapeutics Announces Appointment of Biotech Veteran Heehyoung Lee to Board of Directors […]

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will be sponsoring and attending the 16th Academia Next Generation Precision Oncology Symposium at Moore’s Ca… […]

LA JOLLA—People with bipolar disorder experience dramatic shifts in mood, oscillating between often debilitating periods of mania and depression. While a third of people with bipolar disorder can be successfully treated with the drug lithium, the major… […]